When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ACST - Acasti Pharma's pain is Amarin's gain up 12% premarket
Acasti Pharma Inc.
Acasti Pharma (NASDAQ:ACST) craters 60% premarket on modest volume (thus far) in response to unsuccessful results from a Phase 3 clinical trial, TRILOGY 1, evaluating lead candidate CaPre (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia.
More news on: Acasti Pharma Inc., Amarin Corporation plc, Healthcare stocks news, Stocks on the move,